Definitive Healthcare Corp.
DH- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- SEC CIK
- 0001861795
No open-market purchases or sales by Definitive Healthcare Corp. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $72.8M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 11:01 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $138.9M (57.5% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Jan 16, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | $166.2M |
| Cost of revenue | $58.2M | $54.7M | – | – | – |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | $125.5M |
| Operating expenses | $407.5M | $908.3M | $533.7M | $224.1M | $150.4M |
| Research and development | $34.8M | $36.5M | $42.4M | $34.9M | $18.6M |
| Selling, general and administrative | $51.6M | $49.3M | $58.9M | $51.6M | $30.5M |
| Operating income | -$224.3M | -$710.8M | -$329.8M | -$44.0M | -$25.0M |
| Interest expense | $11.3M | $14.8M | $15.2M | $8.41M | $25.9M |
| Income tax | -$9.96M | -$42.3M | -$18.6M | -$17.7M | $675.0K |
| Net income | -$138.9M | -$413.1M | -$202.4M | -$7.22M | -$17.7M |
| EPS, basic | $-1.30 | $-3.54 | $-1.79 | $-0.07 | – |
| EPS, diluted | $-1.30 | $-3.54 | $-1.79 | $-0.07 | – |
| Weighted shares, basic | 106.7M | 116.6M | 112.8M | 101.1M | – |
| Weighted shares, diluted | 106.7M | 116.6M | 112.8M | 101.1M | – |
| Margins and growth | |||||
| Gross margin | 75.9% | 78.3% | 81.1% | 80.9% | 75.5% |
| Operating margin | -92.9% | -281.8% | -131.2% | -19.8% | -15.0% |
| Net margin | -57.5% | -163.8% | -80.5% | -3.2% | -10.6% |
| Revenue growth, year over year | −4.2% | +0.3% | +12.9% | +34.0% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Jan 16, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Cash and equivalents | $163.6M | $105.4M | $131.0M | $146.9M | $387.5M |
| Short-term investments | $17.3M | $184.8M | $177.1M | $184.9M | – |
| Accounts receivable | $52.0M | $53.2M | $59.2M | $58.8M | $43.3M |
| Total current assets | $257.6M | $370.2M | $393.9M | $413.7M | $444.2M |
| Property, plant and equipment | $12.7M | $3.79M | $4.47M | $4.46M | $5.07M |
| Goodwill | $197.2M | $393.3M | $1.08B | $1.32B | $1.26B |
| Intangible assets | $247.5M | $297.9M | $323.1M | $350.7M | $352.5M |
| Total assets | $735.5M | $1.09B | $1.83B | $2.12B | $2.12B |
| Accounts payable | $3.60M | $10.8M | $5.79M | $3.95M | $4.65M |
| Short-term debt | $8.75M | $13.8M | $13.8M | $8.59M | $6.88M |
| Total current liabilities | $156.8M | $161.2M | $170.7M | $140.6M | $117.8M |
| Long-term debt | $156.1M | $229.4M | $242.6M | $255.8M | $263.8M |
| Total liabilities | $356.5M | $482.2M | $626.7M | $640.7M | $612.7M |
| Shareholders' equity | $379.0M | $607.2M | $1.20B | $1.48B | $1.50B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Jan 16, 2024 | Feb 23, 2023 | Feb 23, 2022 |
| Operating cash flow | $53.8M | $58.2M | $41.2M | $35.6M | $25.2M |
| Capital expenditures | $16.7M | $12.3M | $2.98M | $8.33M | $6.73M |
| Free cash flow | $37.1M | $45.9M | $38.2M | $27.3M | $18.5M |
| Depreciation and amortization | $3.30M | $2.25M | $1.95M | $2.19M | $1.75M |
| Stock-based compensation | $29.1M | $38.1M | $48.7M | $36.4M | $9.96M |
| Share buybacks | $49.5M | $22.4M | – | – | – |
| Investing cash flow | $153.9M | -$26.4M | -$31.8M | -$248.9M | -$46.7M |
| Financing cash flow | -$150.8M | -$56.7M | -$25.6M | -$26.7M | $384.4M |
| Net change in cash | – | – | – | -$240.0M | $362.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 12.1% | 15.1% | 19.4% | 16.4% | 6.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 107.2M | +3.7% | SEC |
| Aug 6, 2026 | 106.7M | +2.6% | SEC |
| May 4, 2026 | 105.5M | −1.7% | SEC |
| Feb 23, 2026 | 104.5M | −7.5% | SEC |
| Nov 3, 2025 | 103.3M | −10.6% | SEC |
| Aug 4, 2025 | 104.1M | −11.1% | SEC |
| May 5, 2025 | 107.3M | −9.0% | SEC |
| Feb 24, 2025 | 112.9M | −4.1% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.